Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.

GC Cell Corporation162 enrolled

Overview

To observation that long term follow-up study of 'Immuncell-LC groups' and 'Non-treatment groups' in patient undergo curative resection (PEIT, RFA or Operation) for hepatocellular carcinoma in Korea

Study Type

OBSERVATIONAL

Enrollment

162

Conditions

Hepatocellular Carcinoma

Eligibility

Sex: ALLMin age: 20 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Prior to the test, patient is fully explained about the purpose/ contents and characteristics of the testing medication, and the patient him(her)self, the guardian or the legal representative signed on written consent. * Patients of participated in the(ClinicalTrials.gov Identifier:NCT00699816)clinical trial. Exclusion Criteria: * Patient who is incongruent to this clinical trial by sub-investigator's opinion.

Locations (5)

Seoul National Hospital

Seoul, South Korea

Samsung Medical Center

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Korea University Guro Hospital

Seoul, South Korea

Korea University Ansan Hospital

Outcomes

Primary Outcomes

To evaluate recurrence-free survival

Radiological test should be operated by dynamic CT(using 64 cut), dynamic MRI or by angiography.

Time frame: up to 3 years

Secondary Outcomes

To determine the response rate to evaluate overall survival and cause specific survival and changes of Alpha feto protein (AFP) figures from baseline to the last observation date.

Time frame: up to 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.